Featuring Dr. Jennie Clarke and Dr. Joslyn Kirby This morning Dr. Jennie Clarke and Dr. Joslyn Kirby gave a wonderful presentation reviewing pertinent medical literature from the last year applicable to current dermatology practice. Confirming what most in the dermatology field already believed, a recent JAMA Dermatology article revealed total unprotected sun exposure is significantly …
Neal Bhatia, MD stopped by the Dermcast studios during the SDPA’s Annual Summer Dermatology Conference 2018, held in Seattle, Washington, to discuss actinic keratosis and the best modalities of treatment currently available.
Actinic keratosis (AKs) is one of the most common diagnoses patients receive from the dermatologist, and the medical cost to treat AKs is close to 2 billion dollars annually. AKs are treated with destructive procedures, such as cryotherapy, curettage, electrocautery, and chemical peels, to prevent malignant transformation, relieve patient symptoms, and improve quality of life …
Day 3 of the SDPA Annual Summer Conference kicked off with Dr. Neal Bhatia presenting on actinic keratoses (AK). He began his lecture by encouraging providers to examine our definition of actinic keratoses to ourselves and patients. Actinic keratoses can be viewed as a symptom of a bigger problem with at least 8% of AKs …
Ingenol mebutate (IngMeb) and diclofenac sodium (DS) are both approved for treating actinic keratosis (AK) on the face and scalp. A recent study compared them head-to-head for efficacy and safety. The authors hypothesized that due to factors such as superior clinical outcomes, favorable tolerability, and shorter treatment duration, IngMeb may be preferred by patients and …
The benefits of colchicine have been reported for many years for joint pain, gout and other inflammatory ailments. The flower from which it is derived, Colchicum autumnale, was mentioned as a remedy as far back as 1500 BCE in an ancient Egyptian manuscript, though the FDA did not approve the derived colchicine for medications until …